Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, provided an update on its ongoing regulatory, compliance, and initial deployment activities for its telehealth platform in Venezuela. The Company continues to advance early-stage deployment, testing, and refinement of the platform, which is accessible through its digital interface at latamedai.org, where it is evaluating system performance, user workflows, and operational capabilities as part of its initial launch.
The telehealth platform is designed to support remote patient engagement, care coordination, and the integration of AI-driven healthcare analytics tools. Current efforts focus on enhancing platform functionality, improving data integration, and optimizing the user experience. In parallel, the Company is working with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. The Company is actively progressing through the regulatory process and coordinating with authorities to address documentation, operational procedures, and compliance standards.
Management anticipates that the permitting process may be completed in the near term, though no assurances can be provided regarding timing or outcome. The Company believes this phase of deployment, testing, and regulatory alignment represents an important step toward broader operational rollout across its target markets. Dr. Kevin Rodan Levy, Chief Executive Officer, stated: "Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals."
The Company continues to advance development and operational deployment of its digital health and AI platform, including telehealth infrastructure and AI-driven healthcare analytics capabilities. For more information, visit catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This update underscores Catalyst Crew's commitment to building a scalable telehealth platform for emerging markets. The successful deployment and regulatory approval in Venezuela could pave the way for expanded operations across Latin America, addressing the growing demand for modernized healthcare delivery systems. The integration of AI-driven analytics further positions the Company to improve access, efficiency, and care coordination in underserved regions.
